XPO1 overexpression is a common feature among many human cancer types, including lymphoma pancreatic, ovarian, glioma, lung, gastric, prostate, and colorectal cancers, and is associated with poor prognosis (Azizian and Li, 2020). Here, XPO1 is linked to glioma.